medical device investing Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
medical device investing Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
medical device investing Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
medical device investing A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
medical device investing A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
medical device investing A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
medical device investing Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
medical device investing Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
medical device investing Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
medical device investing Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
medical device investing Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
